王韵, 李宇红. 肝动脉灌注在结直肠癌肝转移治疗中的应用现状及前景[J]. 中国肿瘤临床, 2015, 42(20): 997-1001. DOI: 10.3969/j.issn.1000-8179.2015.20.845
引用本文: 王韵, 李宇红. 肝动脉灌注在结直肠癌肝转移治疗中的应用现状及前景[J]. 中国肿瘤临床, 2015, 42(20): 997-1001. DOI: 10.3969/j.issn.1000-8179.2015.20.845
Yun WANG, Yuhong LI. Application of hepatic arterial infusion in the treatment of colorectal cancer liver metastasis[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 42(20): 997-1001. DOI: 10.3969/j.issn.1000-8179.2015.20.845
Citation: Yun WANG, Yuhong LI. Application of hepatic arterial infusion in the treatment of colorectal cancer liver metastasis[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 42(20): 997-1001. DOI: 10.3969/j.issn.1000-8179.2015.20.845

肝动脉灌注在结直肠癌肝转移治疗中的应用现状及前景

Application of hepatic arterial infusion in the treatment of colorectal cancer liver metastasis

  • 摘要: 结直肠癌(colorectal cancer ,CRC )是中国最常见的恶性肿瘤之一,肝转移是其主要的转移模式及治疗关键。相对于全身化疗,肝动脉灌注(hepatic arterial infusion,HAI)给药方式可使肝脏局部药物浓度升高,而外周血液中药物浓度较低,全身不良反应相对较低。HAI 化疗在肠癌肝转移的转化化疗、肝切除术后辅助化疗以及肠癌根治性切除术后的肝转移预防方面显示出一定的应用前景。本文就HAI 在肠癌肝转移的治疗现状及前景做一综述。

     

    Abstract: Colorectal cancer is one of the most common malignancies with a high risk of liver metastasis in China. Compared with systemic chemotherapy, hepatic arterial infusion (HAI) transports cytotoxic agents directly into the hepatic artery, leading to the persistent level of medicine in tumor cells and the relative lower systemic concentration. With advances in HAI, this technique has been successfully used not only as the pre- and post-operative chemotherapy for the resection of colorectal liver metastases, but also as an ad -juvant chemotherapy after the colorectal radical surgery to prevent the liver metastasis. This review discusses the application and per -spective of HAI in the treatment of colorectal cancer liver metastasis.

     

/

返回文章
返回